WO1996038428A1 - Derives de n-benzyldioxothiazolidylbenzamide et leur procede de production - Google Patents
Derives de n-benzyldioxothiazolidylbenzamide et leur procede de production Download PDFInfo
- Publication number
- WO1996038428A1 WO1996038428A1 PCT/JP1996/001459 JP9601459W WO9638428A1 WO 1996038428 A1 WO1996038428 A1 WO 1996038428A1 JP 9601459 W JP9601459 W JP 9601459W WO 9638428 A1 WO9638428 A1 WO 9638428A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon atoms
- group
- general formula
- lower alkyl
- halogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU58446/96A AU698896B2 (en) | 1995-06-02 | 1996-05-30 | N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same |
CA002220698A CA2220698C (en) | 1995-06-02 | 1996-05-30 | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
DK96920002T DK0846693T3 (da) | 1995-06-02 | 1996-05-30 | N-benzyldioxothiazolidylbenzamidderivater og fremgangsmåder til fremstilling deraf |
HU9802565A HU225039B1 (en) | 1995-06-02 | 1996-05-30 | N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same |
US08/952,672 US6030990A (en) | 1995-06-02 | 1996-05-30 | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
EP96920002A EP0846693B1 (en) | 1995-06-02 | 1996-05-30 | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
DE69618792T DE69618792T2 (de) | 1995-06-02 | 1996-05-30 | N-benzyldioxothiazolidylbenzamid-derivate und verfahren zu ihrer herstellung |
AT96920002T ATE212341T1 (de) | 1995-06-02 | 1996-05-30 | N-benzyldioxothiazolidylbenzamid-derivate und verfahren zu ihrer herstellung |
US09/292,955 US6001862A (en) | 1995-06-02 | 1999-04-16 | N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same |
US09/482,268 US6147101A (en) | 1995-06-02 | 2000-01-13 | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7/159781 | 1995-06-02 | ||
JP15978195 | 1995-06-02 | ||
JP15313996A JP3144624B2 (ja) | 1995-06-02 | 1996-05-24 | N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
JP8/153139 | 1996-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996038428A1 true WO1996038428A1 (fr) | 1996-12-05 |
Family
ID=26481850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/001459 WO1996038428A1 (fr) | 1995-06-02 | 1996-05-30 | Derives de n-benzyldioxothiazolidylbenzamide et leur procede de production |
Country Status (15)
Country | Link |
---|---|
US (1) | US6030990A (ja) |
EP (1) | EP0846693B1 (ja) |
JP (1) | JP3144624B2 (ja) |
KR (1) | KR100456177B1 (ja) |
CN (2) | CN1069901C (ja) |
AT (1) | ATE212341T1 (ja) |
AU (1) | AU698896B2 (ja) |
CA (1) | CA2220698C (ja) |
DE (1) | DE69618792T2 (ja) |
DK (1) | DK0846693T3 (ja) |
ES (1) | ES2170858T3 (ja) |
HU (1) | HU225039B1 (ja) |
PT (1) | PT846693E (ja) |
TW (1) | TW400328B (ja) |
WO (1) | WO1996038428A1 (ja) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997032863A1 (fr) * | 1996-03-08 | 1997-09-12 | Torii Pharmaceutical Co., Ltd. | Derives de thiazolidine-2,4-dione |
EP0708098B1 (en) * | 1994-10-07 | 1999-03-03 | Sankyo Company Limited | Oxime derivatives, their preparation and their therapeutic use |
EP0745600B1 (en) * | 1995-06-01 | 2001-10-24 | Sankyo Company Limited | Benzimidazole derivatives, their preparation and their therapeutic use |
WO2001081327A1 (fr) * | 2000-04-25 | 2001-11-01 | Kyorin Pharmaceutical Co., Ltd. | Nouveau cristal stable de derive thiazolidinedione et son procede de production |
WO2001096321A1 (fr) * | 2000-06-14 | 2001-12-20 | Kyorin Pharmaceutical Co., Ltd. | Elaboration de derives de thiazolidinedione |
LT4871B (lt) | 1998-09-17 | 2001-12-27 | Bristol-Myers Squibb Company | Ap2 inhibitorius ir derinys, skirti panaudoti diabeto gydymui |
US6756360B1 (en) | 1998-12-24 | 2004-06-29 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
WO2004075815A2 (de) | 2003-02-27 | 2004-09-10 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
JP2005514452A (ja) * | 2002-01-15 | 2005-05-19 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | フェニル(アルキル)カルボン酸誘導体およびジオニックフェニルアルキル複素環誘導体およびそれらの血清グルコースおよび/または血清脂質低下活性を有する医薬としての使用 |
US6927219B2 (en) | 2001-11-12 | 2005-08-09 | Pfizer Inc. | N-alkyl-adamantyl triazinyl benzamide derivatives |
US7148246B2 (en) | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
WO2006131231A1 (de) | 2005-06-09 | 2006-12-14 | Sanofi-Aventis | Azolopyridin-2-on-derivate als inhibitoren von lipasen und phospholipasen |
US7176202B2 (en) | 2002-12-31 | 2007-02-13 | Pfizer Inc. | Benzamide inhibitors of the P2X7 receptor |
US7214677B2 (en) | 2001-11-12 | 2007-05-08 | Pfizer Inc. | Benzamide, heteroarylamide and reverse amides |
US7220876B2 (en) | 2003-02-27 | 2007-05-22 | Sanofi-Aventis Deutschland Gmbh | Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals |
US7220880B2 (en) | 2002-06-19 | 2007-05-22 | Eli Lilly And Company | Amide linker peroxisome proliferator activated receptor modulators |
US7259177B2 (en) | 2003-02-27 | 2007-08-21 | Sanofi-Aventis Deutschland Gmbh | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals |
EP2083006A1 (en) | 2004-04-01 | 2009-07-29 | Sanofi-Aventis Deutschland GmbH | Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
WO2010093601A1 (en) | 2009-02-10 | 2010-08-19 | Metabasis Therapeutics, Inc. | Novel sulfonic acid-containing thyromimetics, and methods for their use |
EP1216980A4 (en) * | 1999-10-01 | 2010-12-08 | Eisai R&D Man Co Ltd | CARBOXYLIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME |
US8048901B2 (en) | 2003-02-27 | 2011-11-01 | Aventis Pharma Deutschland Gmbh | 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals |
EP2428516A1 (en) | 2003-11-19 | 2012-03-14 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE296293T1 (de) | 1999-08-23 | 2005-06-15 | Kyorin Seiyaku Kk | Substituierte benzylthiazolidin-2,4-dion derivate |
HUP0202893A3 (en) | 1999-08-23 | 2004-12-28 | Kyorin Seiyaku Kk | Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them |
EP1213287B1 (en) * | 1999-08-23 | 2005-05-25 | Kyorin Pharmaceutical Co., Ltd. | Substituted benzylthiazolidine-2,4-dione derivatives |
ATE296815T1 (de) * | 1999-08-23 | 2005-06-15 | Kyorin Seiyaku Kk | Substituierte benzylthiazolidin-2,4-dion derivate |
CA2385083C (en) * | 1999-09-17 | 2007-06-05 | Kyorin Pharmaceutical Co., Ltd. | O-anisamide derivatives |
TWI271192B (en) | 1999-11-11 | 2007-01-21 | Kyorin Pharmaceutical Co Ltd | Solid formulation for oral administration |
KR100875335B1 (ko) * | 1999-12-22 | 2008-12-22 | 메타베이시스 테라퓨틱스, 인크. | 신규 비스아미데이트 포스포네이트 프로드러그 |
US6818776B2 (en) * | 2000-02-01 | 2004-11-16 | Kyorin Pharmaceutical Co., Ltd. | Alkali metal salt of thiazolidine-2,4-dione derivative |
AU2001236079A1 (en) * | 2000-03-07 | 2001-09-17 | Kyorin Pharmaceutical Co. Ltd. | Intermediate compounds |
US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
ATE341343T1 (de) * | 2000-12-26 | 2006-10-15 | Sankyo Co | Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel |
US20060287254A1 (en) * | 2001-01-26 | 2006-12-21 | Schering Corporation | Use of substituted azetidinone compounds for the treatment of sitosterolemia |
TW200840563A (en) * | 2001-01-26 | 2008-10-16 | Schering Corp | Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(S) and treatments for vascular indications |
RS51449B (sr) * | 2001-01-26 | 2011-04-30 | Schering Corporation | Kombinacija aktivatora peroksizom proliferator-aktiviranog receptora (ppar) i inhibitora apsorpcije sterola i lečenje vaskularnih indikacija |
CZ20032031A3 (cs) * | 2001-01-26 | 2003-12-17 | Schering Corporation | Farmaceutický prostředek |
NZ542090A (en) * | 2001-01-26 | 2006-09-29 | Schering Corp | Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
CA2434430A1 (en) * | 2001-01-26 | 2002-08-01 | Harry R. Davis | The use of substituted azetidinone compounds for the treatment of sitosterolemia |
US20030053981A1 (en) * | 2001-01-26 | 2003-03-20 | Schering Corporation | Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
US7071181B2 (en) * | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
JP4256166B2 (ja) | 2001-03-28 | 2009-04-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | カルボン酸化合物 |
US7244861B2 (en) | 2001-03-30 | 2007-07-17 | Eisai Co., Ltd. | Benzene compound and salt thereof |
TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
US20030013699A1 (en) * | 2001-05-25 | 2003-01-16 | Davis Harry R. | Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject |
JPWO2002098840A1 (ja) | 2001-06-04 | 2004-09-16 | エーザイ株式会社 | カルボン酸誘導体及びその塩もしくはそのエステルからなる医薬 |
US7371777B2 (en) | 2001-08-17 | 2008-05-13 | Eisai Co., Ltd. | Cyclic compound and PPAR agonist |
US20030119808A1 (en) * | 2001-09-21 | 2003-06-26 | Schering Corporation | Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects |
DE60216300T2 (de) * | 2001-09-21 | 2007-06-28 | Schering Corp. | Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption |
US7056906B2 (en) * | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
AU2003225027A1 (en) * | 2002-04-16 | 2003-11-03 | Merck And Co., Inc. | Combination therapy using a ppar alpha/gamma agonist |
US6821524B2 (en) * | 2002-06-03 | 2004-11-23 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions |
US7071223B1 (en) * | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
DE602004018617D1 (de) * | 2003-03-07 | 2009-02-05 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
US7459442B2 (en) * | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
JP5137228B2 (ja) * | 2003-03-07 | 2013-02-06 | メルク・シャープ・アンド・ドーム・コーポレーション | 高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用 |
CA2525437C (en) * | 2003-05-12 | 2009-04-28 | Pfizer Products Inc. | Benzamide inhibitors of the p2x7 receptor |
BRPI0512781A (pt) * | 2004-06-29 | 2008-04-08 | Pfizer Prod Inc | método para preparação de derivados de 5-{4-(2-hidroxi-propil)-3,5-dioxo-4,5-diidro-3h-[1,2,4]tria zin-2-il}-benzamida através da desproteção dos precursores de protetores de hidroxila |
AU2005258924A1 (en) * | 2004-06-29 | 2006-01-12 | Pfizer Products Inc. | Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3H-`1,2,4!-triazin-2-YK!benzamide derivatives with P2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
CA2572119A1 (en) * | 2004-06-29 | 2006-01-12 | Warner-Lambert Company Llc | Combination therapies utilizing benzamide inhibitors of the p2x7 receptor |
JP2008510018A (ja) * | 2004-08-18 | 2008-04-03 | メタバシス・セラピューティクス・インコーポレイテッド | フルクトース−1,6−ビスホスファターゼの新規チアゾール阻害物質 |
KR100958831B1 (ko) * | 2006-09-19 | 2010-05-24 | 주식회사유한양행 | 헤테로아릴피리미딘 유도체, 이들의 제조방법, 및 이들을포함하는 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01272573A (ja) * | 1988-03-08 | 1989-10-31 | Pfizer Inc | チアゾリジンジオン血糖降下剤 |
JPH05213913A (ja) * | 1991-08-20 | 1993-08-24 | Adir | 新規な2,4−チアゾリジンジオン化合物およびこれらの化合物を含有する医薬組成物 |
JPH05255288A (ja) * | 1991-12-26 | 1993-10-05 | Sankyo Co Ltd | チアゾリジン化合物 |
-
1996
- 1996-05-24 JP JP15313996A patent/JP3144624B2/ja not_active Expired - Fee Related
- 1996-05-30 AT AT96920002T patent/ATE212341T1/de not_active IP Right Cessation
- 1996-05-30 WO PCT/JP1996/001459 patent/WO1996038428A1/ja not_active Application Discontinuation
- 1996-05-30 DK DK96920002T patent/DK0846693T3/da active
- 1996-05-30 ES ES96920002T patent/ES2170858T3/es not_active Expired - Lifetime
- 1996-05-30 CA CA002220698A patent/CA2220698C/en not_active Expired - Fee Related
- 1996-05-30 PT PT96920002T patent/PT846693E/pt unknown
- 1996-05-30 KR KR1019970708916A patent/KR100456177B1/ko not_active IP Right Cessation
- 1996-05-30 US US08/952,672 patent/US6030990A/en not_active Expired - Lifetime
- 1996-05-30 DE DE69618792T patent/DE69618792T2/de not_active Expired - Fee Related
- 1996-05-30 AU AU58446/96A patent/AU698896B2/en not_active Ceased
- 1996-05-30 CN CN96194390A patent/CN1069901C/zh not_active Expired - Fee Related
- 1996-05-30 EP EP96920002A patent/EP0846693B1/en not_active Expired - Lifetime
- 1996-05-30 HU HU9802565A patent/HU225039B1/hu not_active IP Right Cessation
- 1996-06-01 TW TW085106555A patent/TW400328B/zh not_active IP Right Cessation
-
2000
- 2000-10-17 CN CNB001301381A patent/CN1133627C/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01272573A (ja) * | 1988-03-08 | 1989-10-31 | Pfizer Inc | チアゾリジンジオン血糖降下剤 |
JPH05213913A (ja) * | 1991-08-20 | 1993-08-24 | Adir | 新規な2,4−チアゾリジンジオン化合物およびこれらの化合物を含有する医薬組成物 |
JPH05255288A (ja) * | 1991-12-26 | 1993-10-05 | Sankyo Co Ltd | チアゾリジン化合物 |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0708098B1 (en) * | 1994-10-07 | 1999-03-03 | Sankyo Company Limited | Oxime derivatives, their preparation and their therapeutic use |
EP0745600B1 (en) * | 1995-06-01 | 2001-10-24 | Sankyo Company Limited | Benzimidazole derivatives, their preparation and their therapeutic use |
WO1997032863A1 (fr) * | 1996-03-08 | 1997-09-12 | Torii Pharmaceutical Co., Ltd. | Derives de thiazolidine-2,4-dione |
LT4871B (lt) | 1998-09-17 | 2001-12-27 | Bristol-Myers Squibb Company | Ap2 inhibitorius ir derinys, skirti panaudoti diabeto gydymui |
US6756360B1 (en) | 1998-12-24 | 2004-06-29 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
EP1216980A4 (en) * | 1999-10-01 | 2010-12-08 | Eisai R&D Man Co Ltd | CARBOXYLIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME |
WO2001081327A1 (fr) * | 2000-04-25 | 2001-11-01 | Kyorin Pharmaceutical Co., Ltd. | Nouveau cristal stable de derive thiazolidinedione et son procede de production |
US6770133B2 (en) | 2000-04-25 | 2004-08-03 | Kyorin Pharmaceutical Co., Ltd. | Stable crystal of thiazolidinedione derivative and process for producing the same |
WO2001096321A1 (fr) * | 2000-06-14 | 2001-12-20 | Kyorin Pharmaceutical Co., Ltd. | Elaboration de derives de thiazolidinedione |
US6927219B2 (en) | 2001-11-12 | 2005-08-09 | Pfizer Inc. | N-alkyl-adamantyl triazinyl benzamide derivatives |
US7235549B2 (en) | 2001-11-12 | 2007-06-26 | Pfizer Inc. | Benzamide, heteroarylamide and reverse amides |
US7214677B2 (en) | 2001-11-12 | 2007-05-08 | Pfizer Inc. | Benzamide, heteroarylamide and reverse amides |
JP2005514452A (ja) * | 2002-01-15 | 2005-05-19 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | フェニル(アルキル)カルボン酸誘導体およびジオニックフェニルアルキル複素環誘導体およびそれらの血清グルコースおよび/または血清脂質低下活性を有する医薬としての使用 |
US7220880B2 (en) | 2002-06-19 | 2007-05-22 | Eli Lilly And Company | Amide linker peroxisome proliferator activated receptor modulators |
US7176202B2 (en) | 2002-12-31 | 2007-02-13 | Pfizer Inc. | Benzamide inhibitors of the P2X7 receptor |
US7407956B2 (en) | 2002-12-31 | 2008-08-05 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
US7365084B2 (en) | 2003-02-27 | 2008-04-29 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals |
US7148246B2 (en) | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
US7259177B2 (en) | 2003-02-27 | 2007-08-21 | Sanofi-Aventis Deutschland Gmbh | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals |
US7335671B2 (en) | 2003-02-27 | 2008-02-26 | Sanofi-Aventis Deutschland Gmbh | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
US7160911B2 (en) | 2003-02-27 | 2007-01-09 | Sanofi-Aventis Deutschland Gmbh | Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
US7220876B2 (en) | 2003-02-27 | 2007-05-22 | Sanofi-Aventis Deutschland Gmbh | Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals |
WO2004075815A2 (de) | 2003-02-27 | 2004-09-10 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
US7872034B2 (en) | 2003-02-27 | 2011-01-18 | Sanofi-Aventis Deutschland Gmbh | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
US8048901B2 (en) | 2003-02-27 | 2011-11-01 | Aventis Pharma Deutschland Gmbh | 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals |
EP2428516A1 (en) | 2003-11-19 | 2012-03-14 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
EP2083006A1 (en) | 2004-04-01 | 2009-07-29 | Sanofi-Aventis Deutschland GmbH | Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
WO2006131231A1 (de) | 2005-06-09 | 2006-12-14 | Sanofi-Aventis | Azolopyridin-2-on-derivate als inhibitoren von lipasen und phospholipasen |
WO2010093601A1 (en) | 2009-02-10 | 2010-08-19 | Metabasis Therapeutics, Inc. | Novel sulfonic acid-containing thyromimetics, and methods for their use |
Also Published As
Publication number | Publication date |
---|---|
CN1336366A (zh) | 2002-02-20 |
DE69618792T2 (de) | 2002-10-10 |
EP0846693A4 (en) | 1999-03-03 |
DE69618792D1 (de) | 2002-03-14 |
DK0846693T3 (da) | 2002-05-06 |
AU5844696A (en) | 1996-12-18 |
CN1069901C (zh) | 2001-08-22 |
CA2220698C (en) | 2003-06-17 |
HU225039B1 (en) | 2006-05-29 |
AU698896B2 (en) | 1998-11-12 |
EP0846693B1 (en) | 2002-01-23 |
JP3144624B2 (ja) | 2001-03-12 |
CN1186489A (zh) | 1998-07-01 |
CN1133627C (zh) | 2004-01-07 |
US6030990A (en) | 2000-02-29 |
TW400328B (en) | 2000-08-01 |
JPH0948771A (ja) | 1997-02-18 |
CA2220698A1 (en) | 1996-12-05 |
HUP9802565A3 (en) | 2000-01-28 |
EP0846693A1 (en) | 1998-06-10 |
ES2170858T3 (es) | 2002-08-16 |
ATE212341T1 (de) | 2002-02-15 |
KR19990022435A (ko) | 1999-03-25 |
HUP9802565A2 (hu) | 1999-04-28 |
KR100456177B1 (ko) | 2004-12-30 |
PT846693E (pt) | 2002-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996038428A1 (fr) | Derives de n-benzyldioxothiazolidylbenzamide et leur procede de production | |
JP3906935B2 (ja) | N−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 | |
KR100371297B1 (ko) | 치환된티아졸리딘디온유도체 | |
JP3162721B2 (ja) | 新規チアゾリジンジオン及びそれを含有する医薬製剤 | |
WO2002098840A1 (fr) | Derive de l'acide carboxylique et medicament comprenant un sel ou un ester dudit derive | |
JPH0283384A (ja) | 新規化合物、その製法及びそれを含む医薬組成物 | |
WO2008016175A1 (fr) | Agent activant de récepteur activé par les proliférateurs des peroxysomes | |
JP2007536358A (ja) | 抗糖尿病性ロシグリタゾン誘導体の合成 | |
US6001862A (en) | N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same | |
US6147101A (en) | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same | |
JP3929512B2 (ja) | N−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 | |
KR20010102390A (ko) | 폴리사이클릭 2-아미노-티아졸 시스템, 이의 제조방법 및이를 함유하는 약제 | |
JPH09301963A (ja) | N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 | |
JP4010377B2 (ja) | N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 | |
JP5496913B2 (ja) | 代謝異常の治療のための化合物 | |
JPH08325250A (ja) | 新規置換フェノール誘導体 | |
JP2002510283A (ja) | 抗糖尿病性、低脂質性及び抗高血圧性を有する置換チアゾリンジオンとオキサゾリジンジオン | |
JPH0329073B2 (ja) | ||
JP2001139565A (ja) | N−ベンジルジオキソチアゾリジルベンズアミド誘導体の製造中間体およびその製造方法 | |
JPH052675B2 (ja) | ||
JP2518497B2 (ja) | 抗脂血剤 | |
JPH06172310A (ja) | 抗高脂血症作用を有する置換アミン誘導体 | |
JPH08157462A (ja) | ジオキソチアゾリジン誘導体及びそれを含有する医薬組成物 | |
JPH09295977A (ja) | ピリドピリミジン誘導体及びそれを含有する医薬組成物 | |
JPH055832B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96194390.4 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN HU KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996920002 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2220698 Country of ref document: CA Ref document number: 2220698 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970708916 Country of ref document: KR Ref document number: 08952672 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1996920002 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970708916 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996920002 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1019970708916 Country of ref document: KR |